A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme
Uracil–DNA glycosylases are enzymes that excise uracil bases appearing in DNA as a result of cytosine deamination or accidental dUMP incorporation from the dUTP pool. The activity of Family 1 uracil–DNA glycosylase (UNG) activity limits the efficiency of antimetabolite drugs and is essential for vir...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4eccb9b2add64a62a6373d3ddfe88e90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:4eccb9b2add64a62a6373d3ddfe88e90 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:4eccb9b2add64a62a6373d3ddfe88e902021-11-11T18:37:43ZA New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme10.3390/molecules262166681420-3049https://doaj.org/article/4eccb9b2add64a62a6373d3ddfe88e902021-11-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6668https://doaj.org/toc/1420-3049Uracil–DNA glycosylases are enzymes that excise uracil bases appearing in DNA as a result of cytosine deamination or accidental dUMP incorporation from the dUTP pool. The activity of Family 1 uracil–DNA glycosylase (UNG) activity limits the efficiency of antimetabolite drugs and is essential for virulence in some bacterial and viral infections. Thus, UNG is regarded as a promising target for antitumor, antiviral, antibacterial, and antiprotozoal drugs. Most UNG inhibitors presently developed are based on the uracil base linked to various substituents, yet new pharmacophores are wanted to target a wide range of UNGs. We have conducted virtual screening of a 1,027,767-ligand library and biochemically screened the best hits for the inhibitory activity against human and vaccinia virus UNG enzymes. Although even the best inhibitors had IC<sub>50</sub> ≥ 100 μM, they were highly enriched in a common fragment, tetrahydro-2,4,6-trioxopyrimidinylidene (PyO3). In silico, PyO3 preferably docked into the enzyme’s active site, and in kinetic experiments, the inhibition was better consistent with the competitive mechanism. The toxicity of two best inhibitors for human cells was independent of the presence of methotrexate, which is consistent with the hypothesis that dUMP in genomic DNA is less toxic for the cell than strand breaks arising from the massive removal of uracil. We conclude that PyO3 may be a novel pharmacophore with the potential for development into UNG-targeting agents.Inga R. GrinGrigory V. MechetinRustem D. KasymovEvgeniia A. DiatlovaAnna V. YudkinaSergei N. ShchelkunovIrina P. GilevaAlexandra A. DenisovaGrigoriy A. StepanovGhermes G. ChilovDmitry O. ZharkovMDPI AGarticleDNA repairuracil–DNA glycosylaseinhibitorsvirtual screeningpyrimidinesOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6668, p 6668 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
DNA repair uracil–DNA glycosylase inhibitors virtual screening pyrimidines Organic chemistry QD241-441 |
spellingShingle |
DNA repair uracil–DNA glycosylase inhibitors virtual screening pyrimidines Organic chemistry QD241-441 Inga R. Grin Grigory V. Mechetin Rustem D. Kasymov Evgeniia A. Diatlova Anna V. Yudkina Sergei N. Shchelkunov Irina P. Gileva Alexandra A. Denisova Grigoriy A. Stepanov Ghermes G. Chilov Dmitry O. Zharkov A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme |
description |
Uracil–DNA glycosylases are enzymes that excise uracil bases appearing in DNA as a result of cytosine deamination or accidental dUMP incorporation from the dUTP pool. The activity of Family 1 uracil–DNA glycosylase (UNG) activity limits the efficiency of antimetabolite drugs and is essential for virulence in some bacterial and viral infections. Thus, UNG is regarded as a promising target for antitumor, antiviral, antibacterial, and antiprotozoal drugs. Most UNG inhibitors presently developed are based on the uracil base linked to various substituents, yet new pharmacophores are wanted to target a wide range of UNGs. We have conducted virtual screening of a 1,027,767-ligand library and biochemically screened the best hits for the inhibitory activity against human and vaccinia virus UNG enzymes. Although even the best inhibitors had IC<sub>50</sub> ≥ 100 μM, they were highly enriched in a common fragment, tetrahydro-2,4,6-trioxopyrimidinylidene (PyO3). In silico, PyO3 preferably docked into the enzyme’s active site, and in kinetic experiments, the inhibition was better consistent with the competitive mechanism. The toxicity of two best inhibitors for human cells was independent of the presence of methotrexate, which is consistent with the hypothesis that dUMP in genomic DNA is less toxic for the cell than strand breaks arising from the massive removal of uracil. We conclude that PyO3 may be a novel pharmacophore with the potential for development into UNG-targeting agents. |
format |
article |
author |
Inga R. Grin Grigory V. Mechetin Rustem D. Kasymov Evgeniia A. Diatlova Anna V. Yudkina Sergei N. Shchelkunov Irina P. Gileva Alexandra A. Denisova Grigoriy A. Stepanov Ghermes G. Chilov Dmitry O. Zharkov |
author_facet |
Inga R. Grin Grigory V. Mechetin Rustem D. Kasymov Evgeniia A. Diatlova Anna V. Yudkina Sergei N. Shchelkunov Irina P. Gileva Alexandra A. Denisova Grigoriy A. Stepanov Ghermes G. Chilov Dmitry O. Zharkov |
author_sort |
Inga R. Grin |
title |
A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme |
title_short |
A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme |
title_full |
A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme |
title_fullStr |
A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme |
title_full_unstemmed |
A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme |
title_sort |
new class of uracil–dna glycosylase inhibitors active against human and vaccinia virus enzyme |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/4eccb9b2add64a62a6373d3ddfe88e90 |
work_keys_str_mv |
AT ingargrin anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT grigoryvmechetin anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT rustemdkasymov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT evgeniiaadiatlova anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT annavyudkina anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT sergeinshchelkunov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT irinapgileva anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT alexandraadenisova anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT grigoriyastepanov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT ghermesgchilov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT dmitryozharkov anewclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT ingargrin newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT grigoryvmechetin newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT rustemdkasymov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT evgeniiaadiatlova newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT annavyudkina newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT sergeinshchelkunov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT irinapgileva newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT alexandraadenisova newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT grigoriyastepanov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT ghermesgchilov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme AT dmitryozharkov newclassofuracildnaglycosylaseinhibitorsactiveagainsthumanandvacciniavirusenzyme |
_version_ |
1718431760949182464 |